Beck Bode LLC’s Pulmonx LUNG Stock Holding History

Beck Bode LLC’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-135,217	Closed	-$4.34M	–	167
2021 Q4	$4.34M	Buy	135,217 +6,878	+5%	+$251K	1.08%	29
2021 Q3	$4.62M	Buy	128,339 +11,897	+10%	+$468K	1.29%	30
2021 Q2	$5.14M	Buy	+116,442	New	+$5.07M	1.42%	30

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Beck Bode LLC's LUNG Position: Q1 2022 in Review

Beck Bode LLC sold out of Pulmonx (LUNG) in Q1 2022, closing a stake of 135,217 shares — an estimated $4.34M sold.

Beck Bode LLC first reported a position in LUNG in Q2 2021 and held it in 3 quarters. The position peaked at $5.14M in Q2 2021. 109 funds tracked by Wall St. Rank hold LUNG as of Q1 2022.

Beck Bode LLC reported no remaining Pulmonx position as of Q1 2022 after selling out during the quarter.
Beck Bode LLC sold 135,217 Pulmonx shares in Q1 2022, an estimated $4.34M.
Beck Bode LLC first reported a position in Pulmonx in Q2 2021 and held it in 3 quarters.
Beck Bode LLC's Pulmonx position peaked at $5.14M in Q2 2021.
109 funds tracked by Wall St. Rank held Pulmonx as of Q1 2022.

Based on Beck Bode LLC's 13F filing for Q1 2022, filed 2 May 2022.